Nufarm Ltd (ASX:NUF) (Q2 2025) Earnings Call Highlights: Navigating Challenges with Strategic Growth Initiatives

Nufarm Ltd (ASX:NUF) reports mixed results with a focus on inventory reduction, biofuels expansion, and strategic partnerships amid market pressures.

Author's Avatar
May 21, 2025
Summary
  • Underlying EBIT: $103 million, a decrease of 15% year on year.
  • Earnings Per Share (EPS) Before Material Items: $0.72.
  • Leverage: 4.5 times underlying EBITDA.
  • Revenue from Seed Technologies: $249 million.
  • Underlying EBITDA: $206 million, a decrease of 6% year on year.
  • Statutory Net Profit After Tax: $30 million.
  • Net Debt: $1.362 billion, an increase of 12% on the prior year.
  • Capital Expenditure for FY26: Expected to be around $200 million.
  • Inventory Reduction: Achieved a 22-day year-on-year reduction, on track for a 25-day reduction by year-end.
  • Net Working Capital to Sales: 39.2%, a substantial improvement from the prior year.
  • Omega-3 Inventory Write-Down: Negative $28 million due to fish oil market conditions.
  • Return on Funds Employed: 3.2% compared to 3.6% in the prior year.
  • Revenue Growth: 3% increase year on year.
  • Gross Profit Margin: Increased by 50 basis points year on year.
  • Net Operating Cash Flow Movement: Outflow of $459 million due to seasonal net working capital build.
Article's Main Image

Release Date: May 21, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

  • Nufarm Ltd (ASX:NUF, Financial) reported a strong recovery in profitability from crop protection, with underlying EBIT up 34% year on year.
  • The company achieved a 22-day year-on-year reduction in inventory, on track for a 25-day reduction by the end of the financial year.
  • Nufarm Ltd (ASX:NUF) is expanding its biofuels platform, planning a threefold increase in carinata planting area in 2025.
  • The company has formed new agreements with BP and Unilever to develop biomass oil, targeting sustainable oil production for biofuels and FMCG applications.
  • Nufarm Ltd (ASX:NUF) is exploring alternative capital structures for its Seed Technologies to accelerate growth and maximize value.

Negative Points

  • The omega-3 platform negatively impacted results, leading to a $28 million write-down of omega-3 inventories.
  • Nufarm Ltd (ASX:NUF) finished the period with a leverage of 4.5 times, reflecting increased debt levels.
  • The company reported a decline in underlying EBITDA by 6% year on year, and underlying EBIT decreased by 15%.
  • North America experienced a 10% year-on-year decline in EBIT due to pricing pressures and a delayed season.
  • The fish oil market saw a significant reduction in pricing, impacting sales and profitability for the Aquaterra product.

Q & A Highlights

Q: Why is Nufarm exploring alternative structures for Seed Technologies now, especially with depressed fish oil prices?
A: Gregory Hunt, CEO, explained that Seed Technologies requires more funding than Nufarm alone can provide as it moves to the next growth stage. Despite temporary oversupply affecting omega-3, the long-term demand is positive, and sophisticated investors may see the long-term value in the platform.

Q: What is the outlook for Nufarm's Australian business given the dry conditions?
A: Gregory Hunt, CEO, noted improved margins due to lower costs, but dry conditions have impacted trading since March. The rest of Asia remains stable, and Nufarm plans to prioritize the domestic market while exploring opportunities in North America.

Q: Is the current poor market environment in North America temporary, or is there a structural issue?
A: Gregory Hunt, CEO, stated that the market operates on a just-in-time basis, with uncertainty around tariffs causing cautious channel purchasing. However, with low channel inventories, Nufarm expects improved volumes in the second half.

Q: Can you provide details on the supplier financing utilization?
A: Brendan Ryan, CFO, confirmed that supplier financing was approximately AUD125 million, consistent with the previous year's position.

Q: How does Nufarm plan to address the 4.5 times net debt to EBITDA leverage?
A: Brendan Ryan, CFO, outlined actions to deleverage, including reducing CapEx, scaling back omega-3, achieving cost savings, and introducing new products. These actions are expected to bring leverage back to the target range of 1.5 to 2 times EBITDA by FY26.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.